8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Age-related loss of neural stem cell O-GlcNAc promotes a glial fate switch through STAT3 activation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          Depletion of the neural stem cell (NSC) pool is a major driver of age-related regenerative decline in the hippocampus. While increased quiescence is a major contributor to this decline, NSCs can also undergo terminal differentiation into astrocytes, thus restricting the stem cell pool. The mechanisms underlying this fate switch and their relation to age-related regenerative decline have not yet been fully elucidated. In this study, we report an age-related decline in NSC O-GlcNAcylation, coincident with reduced neurogenesis and increased gliogenesis. We identify loss of O-GlcNAcylation at STAT3 T717 in the hippocampus with age, and demonstrate that O-GlcNAcylation of this site is a critical determinant of NSC fate. Our work expands our understanding of how posttranslational modifications influence the aging brain.

          Abstract

          Increased neural stem cell (NSC) quiescence is a major determinant of age-related regenerative decline in the adult hippocampus. However, a coextensive model has been proposed in which division-coupled conversion of NSCs into differentiated astrocytes restrict the stem cell pool with age. Here we report that age-related loss of the posttranslational modification, O-linked β- N-acetylglucosamine (O-GlcNAc), in NSCs promotes a glial fate switch. We detect an age-dependent decrease in NSC O-GlcNAc levels coincident with decreased neurogenesis and increased gliogenesis in the mature hippocampus. Mimicking an age-related loss of NSC O-GlcNAcylation in young mice reduces neurogenesis, increases astrocyte differentiation, and impairs associated cognitive function. Using RNA-sequencing of primary NSCs following decreased O-GlcNAcylation, we detected changes in the STAT3 signaling pathway indicative of glial differentiation. Moreover, using O-GlcNAc–specific mass spectrometry analysis of the aging hippocampus, together with an in vitro site-directed mutagenesis approach, we identify loss of STAT3 O-GlcNAc at Threonine 717 as a driver of astrocyte differentiation. Our data identify the posttranslational modification, O-GlcNAc, as a key molecular regulator of regenerative decline underlying an age-related NSC fate switch.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Quiescent and active hippocampal neural stem cells with distinct morphologies respond selectively to physiological and pathological stimuli and aging.

          New neurons are generated in the adult hippocampus throughout life by neural stem/progenitor cells (NSCs), and neurogenesis is a plastic process responsive to external stimuli. We show that canonical Notch signaling through RBP-J is required for hippocampal neurogenesis. Notch signaling distinguishes morphologically distinct Sox2(+) NSCs, and within these pools subpopulations can shuttle between mitotically active or quiescent. Radial and horizontal NSCs respond selectively to neurogenic stimuli. Physical exercise activates the quiescent radial population whereas epileptic seizures induce expansion of the horizontal NSC pool. Surprisingly, reduced neurogenesis correlates with a loss of active horizontal NSCs in aged mice rather than a total loss of stem cells, and the transition to a quiescent state is reversible to rejuvenate neurogenesis in the brain. The discovery of multiple NSC populations with Notch dependence but selective responses to stimuli and reversible quiescence has important implications for the mechanisms of adaptive learning and also for regenerative therapy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Blood factors transfer beneficial effects of exercise on neurogenesis and cognition to the aged brain

            Reversing brain aging may be possible through systemic interventions such as exercise. We found that administration of circulating blood factors in plasma from exercised aged mice transferred the effects of exercise on adult neurogenesis and cognition to sedentary aged mice. Plasma concentrations of glycosylphosphatidylinositol (GPI)–specific phospholipase D1 (Gpld1), a GPI-degrading enzyme derived from liver, were found to increase after exercise and to correlate with improved cognitive function in aged mice, and concentrations of Gpld1 in blood were increased in active, healthy elderly humans. Increasing systemic concentrations of Gpld1 in aged mice ameliorated age-related regenerative and cognitive impairments by altering signaling cascades downstream of GPI-anchored substrate cleavage. We thus identify a liver-to-brain axis by which blood factors can transfer the benefits of exercise in old age.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse.

              O-linked N-acetylglucosamine (O-GlcNAc) is a dynamic, reversible monosaccharide modifier of serine and threonine residues on intracellular protein domains. Crosstalk between O-GlcNAcylation and phosphorylation has been hypothesized. Here, we identified over 1750 and 16,500 sites of O-GlcNAcylation and phosphorylation from murine synaptosomes, respectively. In total, 135 (7%) of all O-GlcNAcylation sites were also found to be sites of phosphorylation. Although many proteins were extensively phosphorylated and minimally O-GlcNAcylated, proteins found to be extensively O-GlcNAcylated were almost always phosphorylated to a similar or greater extent, indicating the O-GlcNAcylation system is specifically targeting a subset of the proteome that is also phosphorylated. Both PTMs usually occur on disordered regions of protein structure, within which, the location of O-GlcNAcylation and phosphorylation is virtually random with respect to each other, suggesting that negative crosstalk at the structural level is not a common phenomenon. As a class, protein kinases are found to be more extensively O-GlcNAcylated than proteins in general, indicating the potential for crosstalk of phosphorylation with O-GlcNAcylation via regulation of enzymatic activity.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc. Natl. Acad. Sci. U.S.A
                pnas
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                8 September 2020
                26 August 2020
                26 August 2020
                : 117
                : 36
                : 22214-22224
                Affiliations
                [1] aDepartment of Anatomy, University of California, San Francisco , CA 94143;
                [2] bDevelopmental and Stem Cell Biology Graduate Program, University of California, San Francisco , CA 94143;
                [3] cMass Spectrometry Facility, Department of Pharmaceutical Chemistry, University of California, San Francisco , CA 94158;
                [4] dDepartment of Genetics, Stanford University School of Medicine , Stanford, CA 94305;
                [5] eDepartment of Physical Therapy and Rehabilitation Science, University of California, San Francisco , CA 94143;
                [6] fThe Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, University of California, San Francisco , CA 94143
                Author notes
                2To whom correspondence may be addressed. Email: Saul.Villeda@ 123456ucsf.edu .

                Edited by Gail Mandel, Oregon Health and Science University, Portland, OR, and approved August 4, 2020 (received for review April 20, 2020)

                Author contributions: C.W.W., X.F., and S.A.V. designed research; C.W.W., X.F., and J.C.M. performed research; J.C.M., E.G.W., G.B., J.C., and A.L.B. contributed new reagents/analytic tools; C.W.W., X.F., J.C.M., and J.C. analyzed data; and C.W.W. and S.A.V. wrote the paper.

                1C.W.W. and X.F. contributed equally to this work.

                Author information
                https://orcid.org/0000-0001-7838-5420
                https://orcid.org/0000-0001-5459-8827
                https://orcid.org/0000-0003-0737-231X
                https://orcid.org/0000-0002-2378-4595
                https://orcid.org/0000-0002-8403-7307
                Article
                202007439
                10.1073/pnas.2007439117
                7486730
                32848054
                59a71ea8-7e59-49ba-b00b-64e0cb9f5903
                Copyright © 2020 the Author(s). Published by PNAS.

                This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).

                History
                Page count
                Pages: 11
                Funding
                Funded by: Howard Hughes Medical Institute (HHMI) 100000011
                Award ID: NA
                Award Recipient : Jason C. Maynard Award Recipient : Alma L. Burlingame
                Funded by: HHS | NIH | National Institute of General Medical Sciences (NIGMS) 100000057
                Award ID: 8P41GM103481
                Award Recipient : Jason C. Maynard Award Recipient : Alma L. Burlingame
                Funded by: Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) 100005984
                Award ID: NA
                Award Recipient : Jason C. Maynard Award Recipient : Alma L. Burlingame
                Funded by: HHS | National Institutes of Health (NIH) 100000002
                Award ID: F31-AG050415
                Award Recipient : Elizabeth G. Wheatley
                Funded by: HHS | NIH | National Institute on Aging (NIA) 100000049
                Award ID: R01 AG055797
                Award Recipient : Charles White Award Recipient : XUELAI FAN Award Recipient : Jason C. Maynard Award Recipient : Elizabeth G. Wheatley Award Recipient : Gregor Bieri Award Recipient : Julien Couthouis Award Recipient : Alma L. Burlingame Award Recipient : Saul Villeda
                Funded by: HHS | NIH | National Institute on Aging (NIA) 100000049
                Award ID: RF1 AG062357
                Award Recipient : Charles White Award Recipient : XUELAI FAN Award Recipient : Jason C. Maynard Award Recipient : Elizabeth G. Wheatley Award Recipient : Gregor Bieri Award Recipient : Julien Couthouis Award Recipient : Alma L. Burlingame Award Recipient : Saul Villeda
                Funded by: Marc and Lynne Benioff
                Award ID: NA
                Award Recipient : Saul Villeda
                Categories
                Biological Sciences
                Cell Biology

                neural stem cells,aging,o-glcnacylation,neurogenesis,gliogenesis

                Comments

                Comment on this article